D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
PUT
Hershey
HSY
$37.3B
| $3.38M | ﹤0.01% |
20,000
+10,000
| +100% | +$1.77M |
|
2352
PUT
Protolabs
PRLB
$1.7B
| $3.38M | ﹤0.01% |
50,800
+26,600
| +110% | +$2.08M |
|
2353
Metropolitan Bank Holding Corp
MCB
$1.15B
| $3.38M | ﹤0.01% |
40,107
+23,895
| +147% | +$1.74M |
|
2354
Talphera
TLPH
$68M
| $3.38M | ﹤0.01% |
165,704
-72,722
| -31% | -$1.67M |
|
2355
PUT
Autohome
ATHM
$2.61B
| $3.37M | ﹤0.01% |
71,900
+34,100
| +90% | +$1.61M |
|
2356
PUT
Realty Income
O
$61.1B
| $3.37M | ﹤0.01% |
53,664
+2,064
| +4% | +$139K |
|
|
BSLK
2357
DELISTED
Bolt Projects Holdings
BSLK
| $3.37M | ﹤0.01% |
+17,247
| New | +$3.35M |
|
2358
Nutrien
NTR
$33.9B
| $3.37M | ﹤0.01% |
51,949
-18,522
| -26% | -$1.13M |
|
|
UCB
2359
United Community Banks
UCB
$4.26B
| $3.37M | ﹤0.01% |
102,532
-17,747
| -15% | -$532K |
|
|
DNAB
2360
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| $3.36M | ﹤0.01% |
340,466
+240,466
| +240% | +$2.37M |
|
2361
Acco Brands
ACCO
$399M
| $3.36M | ﹤0.01% |
391,433
-132,583
| -25% | -$1.17M |
|
|
GLSPT
2362
DELISTED
Global SPAC Partners Co. Subunit
GLSPT
| $3.36M | ﹤0.01% |
+336,231
| New | +$3.34M |
|
|
APR
2363
DELISTED
Apria, Inc. Common Stock
APR
| $3.36M | ﹤0.01% |
90,334
+72,134
| +396% | +$2.37M |
|
2364
Principal Financial Group
PFG
$24.3B
| $3.35M | ﹤0.01% |
52,019
-20,390
| -28% | -$1.31M |
|
2365
CALL
KLA
KLAC
$222B
| $3.35M | ﹤0.01% |
100,000
| – | – |
|
|
2366
PUT
KLA
KLAC
$222B
| $3.35M | ﹤0.01% |
100,000
| – | – |
|
2367
PUT
Lumentum
LITE
$46.9B
| $3.34M | ﹤0.01% |
40,000
| – | – |
|
|
RKTA
2368
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
| $3.34M | ﹤0.01% |
342,050
+175,384
| +105% | +$1.7M |
|
|
TRHC
2369
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $3.33M | ﹤0.01% |
126,920
+86,429
| +213% | +$3.18M |
|
|
EVFM
2370
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $3.33M | ﹤0.01% |
300,155
-2,414
| -0.8% | -$30.3K |
|
2371
CALL
Ralph Lauren
RL
$22.3B
| $3.32M | ﹤0.01% |
29,900
-10,000
| -25% | -$1.16M |
|
|
GLS
2372
DELISTED
Gelesis Holdings, Inc.
GLS
| $3.32M | ﹤0.01% |
334,586
+107,849
| +48% | +$1.06M |
|
|
PMVC
2373
DELISTED
PMV Consumer Acquisition Corp.
PMVC
| $3.32M | ﹤0.01% |
338,344
+92,798
| +38% | +$905K |
|
2374
UBS Group
UBS
$170B
| $3.32M | ﹤0.01% |
208,078
-677,652
| -77% | -$11M |
|
|
TMTS
2375
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
| $3.31M | ﹤0.01% |
327,018
| – | – |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.